Sex-Selection Abortion is taken up by the US Congress.


A recent poll shows that 77% of Americans are opposed to sex-selection abortion. This is the real war against women. Sex-selection occurs, for the most part, because couples do not want a little girl. This odious practice is being targeted by the Prenatal Nondescrimination Act. While this act might pass the House, it will probably die in the Democrat-dominated Senate.

The President is indicating that he is against this legislation. He is too far into the pockets of Planned Parenthood to support this legislation.

This act should be passed.  Abortion because the baby is female is horrific.  As David Bass puts it:  “pro-choice ideology claims to place the highest value on women and womanhood. Yet they are forced to accept, as both moral and legal, the aborting of an unborn baby strictly because she is female. To do anything less would violate their core beliefs about the un-personhood of the fetus and the absolute autonomy of the parents (specifically, the mother) in deciding whether to terminate the unborn life.”

Pro-choice advocates want abortion at any cost and for any reason, but sex-selection abortion is what we get when we allow abortion for any reason.  Murdering women because they are women is the ultimate misogyny, and defending it is complicity with such misogyny.  This simple fact of the matter is that pro-choice advocates are not pro-choice, they are pro-abortion.  See the following articles by David Bass at the American Spectator see here, and here.

Update – June 1, 2012 Wall Street Journal reported that the Prenatal Nondiscrimination Act failed to pass the House.

The First Limbal Stem Cell Transplant with Cultured Limbal Stem Cells from a Cadaver


A genetic condition called “aniridia” results from mutations in the PAX6 gene. Approximately 1/50,000-1/1000,000 babies have aniridia. Aniridia results in the complete absence of an iris, and aniridia patients are unable to adjust to light differences.

Because mutations in the PAX6 gene are dominant, aniridia patients half a 50% chance of passing the aniridia condition to their children.

Fortunately for aniridia patients, limbal stem cells can now be cultured in the laboratory and used in clinical settings (see Di Iorio E, et al., Ocul Surf. 2010;8(3):146-53). A Scottish woman with aniridia has just received on of the first limbal stem cell transplants from a cadaver. These cadaver limbal stem cells were cultured and then transplanted onto the surface of her eye.

This woman, Sylvia Paton, who is 50 years old and from the Scottish town of Corstorphine (a west suburb of Edinburgh), is the first person in the United Kingdom to experience this ground-breaking treatment in February of 2012. Her procedure will hopefully reduce her vision problems and ready her for another procedure whereby her lens will be replaced.

For this procedure, limbal stem cells from a dead donor were cultured in the laboratory. The cells were attached to a membrane and then transplanted onto the surface of the left eye. The operation took a total of three hours.

Before her operation, Mrs. Paton could previously only see dark and light through her eye, but this treatment should repair her cornea, and prepare her for another surgery one year later to remove her cataract.

Dr Ashish Agrawal, the National Health Service consultant ophthalmologist who performed the operation, said: “It is now 12 weeks since the transplant and I am delighted to report that Sylvia is recovering well. Her cornea is clear and I hope that it will continue to maintain clarity. However, this is the first and the major step in the complex visual rehabilitation process and she will require further surgical treatment to restore vision.”

We wish Mrs. Paton well and hope that her vision continues to improve.